Tariq H, Kamal MU, Patel H, Patel R, Ameen M, Elona S, Khalifa M, Azam S, Zhang A, Kumar K, Baiomi A, Shaikh D, Makker J. Predicting the presence of adenomatous polyps during colonoscopy with National Cancer Institute Colorectal Cancer Risk-Assessment Tool. World J Gastroenterol 2018; 24(34): 3919-3926 [PMID: 30228785 DOI: 10.3748/wjg.v24.i34.3919]
Corresponding Author of This Article
Muhammad Umar Kamal, MD, Doctor, Resident Physician, Department of Medicine, BronxCare Health system, 1650 Selwyn Avenue, Apt 10C, Bronx, NY 10457, United States. muhammadumarkamal@gmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Sep 14, 2018; 24(34): 3919-3926 Published online Sep 14, 2018. doi: 10.3748/wjg.v24.i34.3919
Table 1 Demographic information stratified by adenomatous polyp prevalence n (%)
Adenoma absent
Adenoma present
Total
P value
Total
436 (58.2)
313 (41.79)
749 (100)
Age
0.043
Mean ± SD
58.656 ± 7.321
59.764 10 ± 7.417
59.119 ± 7.376
Gender
0.798
Male
180 (41.3)
133 (42.5)
313 (41.8)
Female
256 (58.7)
180 (57.5)
436 (58.2)
Race
0.243
White
29 (6.7)
33 (10.6)
62 (8.3)
African american
104 (23.9)
74 (23.7)
178 (23.8)
Asian
5 (1.1)
2 (0.6)
7 (0.9)
Hispanic
298 (68.3)
203 (65.1)
501 (67.0)
Indication of colonoscopy
0.279
Surveillance
77 (17.7)
66 (21.1)
143 (19.1)
Screening
359 (82.3)
247 (78.9)
606 (80.9)
Table 2 Adenoma prevalence by risk-score quintile for all patients
NCI lifetime risk score quintile
Score range
Number of individuals with adenomas (%)
OR of an adenoma (95%CI): row quintile vs column quintile
Q1
Q2
Q3
Q4
Q1 lowest
(1.1, 1.9)
42 (27.63)
-
-
-
-
Q2
(1.9, 2.8)
55 (33.54)
1.32 (0.82, 2.14)
-
-
-
Q3
(2.8, 4.0)
69 (46.31)
2.26 (1.40, 3.65)
1.71 (1.08, 2.70)
-
-
Q4
(4.0, 5.4)
71 (52.21)
2.86 (1.75, 4.67)
2.16 (1.36, 3.45)
1.27 (0.79, 2.02)
-
Q5 highest
(5.4, 12.3)
76 (51.35)
2.76 (1.71, 4.47)
2.09 (1.32, 3.30)
1.22 (0.78, 1.93)
0.97 (0.61, 1.54)
Table 3 Disease prevalence stratified by risk score optimal cutoff value n (%)
< 3.6 (n = 373)
≥ 3.6 (n = 376)
Total (n = 749)
P value
Adenoma present
115 (30.8)
198 (52.7)
313 (41.8)
< 0.001
Adenoma (number)
< 0.001
< 3
355 (95.2)
321 (85.4)
676 (90.3)
≥ 3
18 (4.8)
55 (14.6)
73 (9.7)
Serrated adenoma present
1 (0.3)
2 (0.5)
3 (0.4)
1.000
Hyperplastic polyp > 10 mm present
7 (1.9)
10 (2.7)
17 (2.3)
0.632
Table 4 Adenoma prevalence by risk-score quintile for all screening patients
NCI lifetime risk score quintile
Score range
Number of individuals with adenomas (%)
OR of an adenoma (95%CI): row quintile vs column quintile
Q1
Q2
Q3
Q4
Q1 lowest
(1.1, 1.9)
35 (28.69)
-
-
-
-
Q2
(1.9, 2.8)
45 (33.58)
1.26 (0.74, 2.14)
-
-
-
Q3
(2.8, 4.0)
52 (43.70)
1.93 (1.13, 3.29)
1.53 (0.92, 2.56)
-
-
Q4
(4.0, 5.5)
62 (51.67)
2.66 (1.56, 4.52)
2.11 (1.27, 3.51)
1.38 (0.83, 2.29)
-
Q5 highest
(5.5, 12.3)
53 (47.75)
2.27 (1.32, 3.90)
1.81 (1.08, 3.03)
1.18 (0.70, 1.98)
0.85 (0.51, 1.43)
Citation: Tariq H, Kamal MU, Patel H, Patel R, Ameen M, Elona S, Khalifa M, Azam S, Zhang A, Kumar K, Baiomi A, Shaikh D, Makker J. Predicting the presence of adenomatous polyps during colonoscopy with National Cancer Institute Colorectal Cancer Risk-Assessment Tool. World J Gastroenterol 2018; 24(34): 3919-3926